Top news of the week: 05.01.2021.
Companies And Industries
Top 2020 Biopharma Scandals and Outrages
Over the course of 2020, the biopharmaceutical industry came together to rapidly address the global COVID-19 crisis. Despite that spirit of comradery and partnership, there were still a few ...
Top 2020 Biopharma M&A Deals
BioSpace highlights a number of the key M&A deals struck over the past 12 months.
2020 Year in Review: Biopharma vs. COVID-19
Thanks to the pandemic caused by the SARS-CoV-2 coronavirus identified in late December 2019, 2020 was the year of COVID-19. It was a year of lockdowns and social distancing, a year of Zoom ...
The biotech 2021 preview, from M&A to gene therapy and more
Here are some trends and burning questions for the biotech industry that are on our radar screen for 2021.
India's Vaccine Wait Over; Serum Institute, Bharat Biotech Get Approval
Two vaccines for coronavirus, Oxford Institute's Covishield, which is being developed by the Pune-based Serum Institute, and Bharat Biotech's Covaxin, received emergency approval from the ...
Terms are set in the new year’s first IPOs
Following a record-shattering year, terms were set for the first two biotech IPOs of 2021 in deals that could generate up to $300 million. Cullinan Oncology LLC, of Cambridge, Mass., set ...
How Smart Medicine And Biotech Are Impacting Employer Health Plans In The Digital Age
With the advent of biotech and “smart health” plans, however, employer health plans are going further when it comes to incentivizing employee health.
China approves its first COVID-19 vaccine
Chinese regulators granted a first approval for general use to a COVID-19 vaccine to China National Biotec Group’s (CNBG) BBIBP-CorV. “The NMPA granted conditional approval to the vaccine ...